ATAVISTIK BIO
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.
ATAVISTIK BIO
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.atavistikbio.com
Total Employee:
11+
Status:
Active
Total Funding:
100 M USD
Technology used in webpage:
Google Maps Google Google Cloud
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lux Capital
Lux Capital investment in Venture Round - Atavistik Bio
Nextech Invest
Nextech Invest investment in Venture Round - Atavistik Bio
The Column Group
The Column Group investment in Venture Round - Atavistik Bio
Lux Capital
Lux Capital investment in Series A - Atavistik Bio
The Column Group
The Column Group investment in Series A - Atavistik Bio
Nextech Invest
Nextech Invest investment in Series A - Atavistik Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2023-07-17 | Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer |
Official Site Inspections
http://www.atavistikbio.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.12 K
- Host name: 87.163.198.104.bc.googleusercontent.com
- IP address: 104.198.163.87
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Atavistik Bio"
Atavistik Bio
At Atavistik Bio, we are revolutionizing the discovery of precision allosteric small molecules. Our highly integrated proprietary drug discovery platform enables us to unlock novel allosteric binding pockets and rapidly advance structural …See details»
Atavistik Bio - Crunchbase Company Profile & Funding
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.See details»
Atavistik Bio - LinkedIn
Atavistik Bio Biotechnology Research Cambridge, MA 2,060 followers Precision allosteric therapeutics inspired by the body’s natural regulatorsSee details»
Atavistik Bio Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Atavistik Bio. Use the PitchBook Platform to explore the full profile.See details»
Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer
Jul 17, 2023 For more information, visit atavistikbio.com and follow us on LinkedIn. Media Contact: Liz Melone [email protected] << Back to all Press Releases ©2024 Atavistik Bio.See details»
Atavistik Bio - VentureRadar
Atavistik Bio’s high-throughput platform for the unbiased identification of metabolite-protein interactions, will enable us to discover... ... Find out more about ...See details»
Atavistik Bio | VentureRadar
Website: https://atavistikbio.com/ Develops precision allosteric therapeutics using proprietary screening technology and an AI-enabled drug discovery platform ...See details»
Atavistik Bio Announces $60 Million Series A Financing …
Aug 24, 2021 Atavistik has opened a new office in Cambridge at 38 Sidney St. To learn more, please visit AtavistikBio.com. About Atavistik Bio. Atavistik Bio (Atavistik) is a pre-clinical stage biotechnology ...See details»
Atavistik Bio : Announces $60 Million Series A Financing to …
Aug 24, 2021 Atavistik has opened a new office in Cambridge at 38 Sidney St. To learn more, please visit AtavistikBio.com. About Atavistik Bio. Atavistik Bio (Atavistik) is a pre-clinical stage …See details»
Who Owns Atavistik Bio – CBM
2 days ago Website: atavistikbio.com; Focus: ... Employees may have a smaller ownership stake, but their contributions are still valued within the organization. Overall, the ownership …See details»
Atavistik Bio Announces Formation of Scientific Advisory Board
Sep 20, 2022 Atavistik Bio is located in Cambridge, Massachusetts. For more information, visit www.atavistikbio.com. Contact. Meriel McCaffery Ford Hutman Media …See details»
Atavistik Bio secures $60M series A to tackle metabolic diseases ...
Aug 24, 2021 Atavistik is getting started with Josey and Marion Dorsch, Ph.D., who is serving as president and chief scientific officer. Josey was CEO of Keytruda-challenger Peloton …See details»
How Does Atavistik Bio Work? – CBM
2 days ago Website: atavistikbio.com; Focus: Discovery and development of novel therapies for metabolic diseases and cancer; Atavistik Bio is committed to making a meaningful impact on …See details»
Atavistik Bio Raises Additional $40 Million to Advance Precision ...
Dec 19, 2023 Proceeds will support lead precision oncology program into the clinic and advance earlier stage pipelineAtavistik Bio is discovering transformative precision allosteric small …See details»
Atavistik Bio Raises Additional $40 Million to - GlobeNewswire
Dec 19, 2023 Proceeds will support lead precision oncology program into the clinic and advance earlier stage pipeline; Atavistik Bio is discovering transformative precision allosteric small …See details»
Company News Archive - Atavistik Bio
Oct 23, 2024 To learn more, please visit AtavistikBio.com. About Atavistik Bio Atavistik Bio (Atavistik) is a pre-clinical stage biotechnology company pioneering the identification of …See details»
Atavistik Bio Announces Collaboration with Plex Research to
Jan 10, 2023 For more information, visit www.atavistikbio.com. About Plex Research. Plex Research has developed a novel form of artificial intelligence (AI) based on search engine …See details»
Our Science - Atavistik Bio
We have successfully adapted our platform to screen and identify functional pockets on a broad range of protein classes as well as RNA. While our internal pipeline is focused on high value …See details»
Working at Atavistik
At Atavistik Bio, we are on a mission to discover precision allosteric therapeutics that can transform the treatment of serious diseases. The driving force to achieve our goals comes …See details»